Omega-3脂肪酸生物标志物与新发心房颤动
该研究基于17项前瞻性队列研究的个体水平数据,共纳入54,799名参与者,中位随访13.3年期间 ascertain 7,720例新发心房颤动。多变量分析显示,EPA水平与新发房颤无关,DPA、DHA及EPA+DHA较高水平与房颤风险轻度降低相关;体内Omega-3脂肪酸水平未增加新发房颤风险。
要点
- EPA水平与新发房颤无关(HR 1.00,95%CI 0.95-1.05)。
- DPA、DHA及EPA+DHA较高水平与房颤风险轻度降低相关。
- 习惯性膳食摄入Omega-3脂肪酸在房颤风险方面未见增加。
核心结论
- 体内Omega-3脂肪酸(包括EPA、DPA、DHA及EPA+DHA)水平与新发房颤风险增加无关。
- 研究数据提示习惯性膳食摄入Omega-3脂肪酸在房颤风险方面是安全的。
- 结合Omega-3脂肪酸在预防不良冠脉事件中的已知获益,当前推荐鱼类/Omega-3脂肪酸摄入的膳食指南可以维持。
研究设计与样本
- 研究使用全球联盟17项前瞻性队列研究的参与者水平数据,每项研究均有基线的血液或脂肪组织Omega-3脂肪酸水平及房颤结局数据。
- 每项参与研究按照预设分析计划进行de novo分析,暴露、结局、协变量和亚组定义均统一。
- 关联通过逆方差加权荟萃分析进行合并。
主要发现
- 共纳入17个队列的54,799名参与者,中位随访13.3年期间确定7,720例新发房颤。
- 多变量分析中,EPA水平与新发房颤无关,每跨五分位间距(即第90与第10百分位之差)的HR为1.00(95%CI 0.95-1.05)。
- DPA较高水平的HR为0.89(95%CI 0.83-0.95),DHA为0.90(95%CI 0.85-0.96),EPA+DHA为0.93(95%CI 0.87-0.99)。
关键数值与推荐
- EPA每跨五分位间距的HR为1.00(95%CI 0.95-1.05),与新发房颤无关。
- DPA较高水平的HR为0.89(95%CI 0.83-0.95)。
- DHA较高水平的HR为0.90(95%CI 0.85-0.96)。
- EPA+DHA较高水平的HR为0.93(95%CI 0.87-0.99)。
临床怎么用
- 对于房颤风险担忧的患者,体内Omega-3脂肪酸水平未见增加新发房颤风险。
- 结合Omega-3脂肪酸在预防冠脉事件中的已知获益,可维持当前推荐鱼类/Omega-3脂肪酸摄入的膳食指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between omega-3 fatty acids and atrial fibrillation (AF) remains controversial. OBJECTIVES: This study aimed to determine the prospective associations of blood or adipose tissue levels of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with incident AF. METHODS: We used participant-level data from a global consortium of 17 prospective cohort studies, each with baseline data on blood or adipose tissue omega-3 fatty acid levels and AF outcomes. Each participating study conducted a de novo analyses using a prespecified analytical plan with harmonized definitions for exposures, outcome, covariates, and subgroups. Associations were pooled using inverse-variance weighted meta-analysis. RESULTS: Among 54,799 participants from 17 cohorts, 7,720 incident cases of AF were ascertained after a median 13.3 years of follow-up. In multivariable analysis, EPA levels were not associated with incident AF, HR per interquintile range (ie, the difference between the 90th and 10th percentiles) was 1.00 (95% CI: 0.95-1.05). HRs for higher levels of DPA, DHA, and EPA+DHA, were 0.89 (95% CI: 0.83-0.95), 0.90 (95% CI: 0.85-0.96), and 0.93 (95% CI: 0.87-0.99), respectively. CONCLUSIONS: In vivo levels of omega-3 fatty acids including EPA, DPA, DHA, and EPA+DHA were not associated with increased risk of incident AF. Our data suggest the safety of habitual dietary intakes of omega-3 fatty acids with respect to AF risk. Coupled with the known benefits of these fatty acids in the prevention of adverse coronary events, our study suggests that current dietary guidelines recommending fish/omega-3 fatty acid consumption can be maintained.
引用
- Qian F, Tintle N, Jensen PN, et al. Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation. J Am Coll Cardiol. 2023. PMID: 37468189. doi:10.1016/j.jacc.2023.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。